 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/24/2021 |
$2.20 |
$2.26 |
$2.15 |
$2.26 |
87.90K | | 11/26/2021 |
$2.20 |
$2.25 |
$2.18 |
$2.20 |
28.50K | | 11/29/2021 |
$2.15 |
$2.18 |
$2.08 |
$2.12 |
87.40K | | 11/30/2021 |
$2.11 |
$2.11 |
$2.05 |
$2.10 |
25.90K | | 12/01/2021 |
$2.13 |
$2.16 |
$2.01 |
$2.01 |
89.00K |
|
|
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Co.'s pipeline includes three clinical-stage candidates: EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001 (a taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; and osanetant for the treatment of induced Vasomotor Symptoms where Hormone Replacement Therapy is likely contraindicated. | |
|
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on November 24, 2021, ACER opened at $2.20, traded as high as $2.26 and as low as $2.15, and closed at $2.26. Trading volume was a total of 87.90K shares. On November 26, 2021, ACER opened at $2.20, traded as high as $2.25 and as low as $2.18, and closed at $2.20. Trading volume was a total of 28.50K shares. On November 29, 2021, ACER opened at $2.15, traded as high as $2.18 and as low as $2.08, and closed at $2.12. Trading volume was a total of 87.40K shares. On November 30, 2021, ACER opened at $2.11, traded as high as $2.11 and as low as $2.05, and closed at $2.10. Trading volume was a total of 25.90K shares. On December 01, 2021, ACER opened at $2.13, traded as high as $2.16 and as low as $2.01, and closed at $2.01. Trading volume was a total of 89.00K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/05/2011 |
|
| End date: |
12/01/2021 |
|
| Start price/share: |
$11.25 |
|
| End price/share: |
$2.01 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-82.13% |
|
| Average Annual Total Return: |
-15.82% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,787.70 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 11/24/2021 | $2.26 | | 11/26/2021 | $2.20 | | 11/29/2021 | $2.12 | | 11/30/2021 | $2.10 | | 12/01/2021 | $2.01 |
|
|
Free ACER Email Alerts:
